Target Price | $326.40 |
Price | $330.66 |
Deviation | 1.29% |
Number of Estimates | 28 |
28 Analysts have issued a price target American Express 2026 . The average American Express target price is $326.40. This is 1.29% lower than the current stock price. The highest price target is $393.75 19.08% , the lowest is $262.60 20.58% . | |
A rating was issued by 36 analysts: 14 Analysts recommend American Express to buy, 19 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the American Express stock has an average upside potential 2026 of 1.29% . Most analysts recommend the American Express stock at Hold. |
27 Analysts have issued a sales forecast American Express 2025 . The average American Express sales estimate is $72.3b . This is 3.46% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $75.7b 1.07% , the lowest is $69.7b 6.90% .
This results in the following potential growth metrics:
2024 | $71.6b | 6.35% |
---|---|---|
2025 | $72.3b | 0.92% |
2026 | $78.3b | 8.33% |
2027 | $84.5b | 7.91% |
2028 | $88.8b | 5.04% |
2029 | $95.1b | 7.12% |
4 Analysts have issued an American Express EBITDA forecast 2025. The average American Express EBITDA estimate is $26.9b . This is 84.02% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $28.0b 91.31% , the lowest is $26.1b 78.56% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $14.1b | 13.28% |
---|---|---|
2025 | $26.9b | 91.21% |
2026 | $18.8b | 29.98% |
2027 | $24.7b | 31.02% |
2024 | 19.63% | 6.51% |
---|---|---|
2025 | 37.19% | 89.49% |
2026 | 24.03% | 35.39% |
2027 | 29.18% | 21.43% |
32 American Express Analysts have issued a net profit forecast 2025. The average American Express net profit estimate is $10.8b . This is 7.51% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.4b 13.45% , the lowest is $10.3b 2.68% .
This results in the following potential growth metrics and future Net Margins:
2024 | $10.0b | 21.12% |
---|---|---|
2025 | $10.8b | 7.75% |
2026 | $12.1b | 12.74% |
2027 | $13.7b | 12.78% |
2028 | $14.2b | 3.55% |
2029 | $15.2b | 7.49% |
2024 | 13.95% | 13.89% |
---|---|---|
2025 | 14.90% | 6.80% |
2026 | 15.50% | 4.03% |
2027 | 16.20% | 4.52% |
2028 | 15.97% | 1.42% |
2029 | 16.03% | 0.38% |
32 Analysts have issued a American Express forecast for earnings per share. The average American Express EPS is $15.47 . This is 7.96% higher than earnings per share in the financial year 2024. The highest EPS forecast is $16.33 13.96% , the lowest is $14.78 3.14% .
This results in the following potential growth metrics and future valuations:
2024 | $14.02 | 25.07% |
---|---|---|
2025 | $15.47 | 10.34% |
2026 | $17.44 | 12.73% |
2027 | $19.67 | 12.79% |
2028 | $20.37 | 3.56% |
2029 | $21.90 | 7.51% |
Current | 23.07 | 14.97% |
---|---|---|
2025 | 21.37 | 7.39% |
2026 | 18.95 | 11.32% |
2027 | 16.81 | 11.29% |
2028 | 16.23 | 3.45% |
2029 | 15.10 | 6.96% |
Based on analysts' sales estimates for 2025, the American Express stock is valued at an EV/Sales of 5.28 and an P/S ratio of 3.18 .
This results in the following potential growth metrics and future valuations:
Current | 5.10 | 5.59% |
---|---|---|
2025 | 5.28 | 3.50% |
2026 | 4.87 | 7.70% |
2027 | 4.52 | 7.33% |
2028 | 4.30 | 4.80% |
2029 | 4.01 | 6.65% |
Current | 3.07 | 9.95% |
---|---|---|
2025 | 3.18 | 3.58% |
2026 | 2.94 | 7.69% |
2027 | 2.72 | 7.33% |
2028 | 2.59 | 4.80% |
2029 | 2.42 | 6.64% |
American Express...
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 07 2025 |
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Oct 07 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 06 2025 |
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Oct 01 2025 |
Evercore ISI Group |
In-Line
➜
In-Line
|
Unchanged | Sep 30 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 29 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Sep 15 2025 |
Analyst Rating | Date |
---|---|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 07 2025 |
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Oct 07 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 06 2025 |
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Oct 01 2025 |
Unchanged
Evercore ISI Group:
In-Line
➜
In-Line
|
Sep 30 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Sep 29 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Sep 15 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.